AAV Vector CDMO Services
Cell and gene therapy (CGT) has the potential to transform medicine, providing long term and potentially curative treatment options for a wide range of diseases. AAV vector is the most widely used vehicle in delivering gene of interest (GOI) in in vivo gene therapies.
ProBio is aimed to solve difficulties in producing AAV vector, and is expanding its business into AAV services to cover various needs from research through IND application to clinical trials.
-
AAV CDMO
-
Research &
Discovery
IND Filing
Phase I
Phase II
Phase III
BLA/NDA
Commercial
ProAAVAAV CMCGMP Clinical AAVGMP AAV
Our Services
-
ProAAV Manufacturing
Adopting most relevant GMP features, ProAAV fulfills your expectation in non-clinical phases.
-
AAV One-stop Solution
Covering the process development, analytical development, GMP manufacturing and stability; supporting regulatory filings.
-
GMP AAV Manufacturing
GMP AAV vector is manufactured compliant to GMP regulations, suitable for early phase clinical trials. GMP AAV Manufacturing
Our Facility and Experience
-
- 2,000 m2 state-of-the-art facility dedicated for GMP viral vectors manufacturing
- Global partnerships on viral vector projects
-
